Services

Listings
  • ACA652 Probe

    ACA652 Probe

    Drug Development Shirley (New York) September 30, 2026 1.00 Dollar US$

    Cat.No. FBPC-53 Description The identification of microbes: Acinetobacter Size 50 Tests Usage For Research Use Only. Not for use in diagnostic procedures. Storage Store at minus 20 centigrade https://www.creative-bioarray.com/aca652-probe-item-fbpc-5...

  • RH-30

    RH-30

    Drug Development Shirley (New York) September 30, 2026 1.00 Dollar US$

    Established from the bone marrow metastasis of a 17-year-old man with undifferentiated (standard classification) or unclassified (Palmer classification) alveolar rhabdomyosarcoma; cells were described as carrying a p53 mutation, expressing high level...

  • UKE-1

    UKE-1

    Drug Development Shirley (New York) September 30, 2026 1.00 Dollar US$

    Cat.No. CSC-C2301J Description established from peripheral blood of a 59-year-old woman with Essential thrombocythemia Species Homo sapiens (Human) Source Blood; Peripheral Blood Recommended Medium RPMI- 1640 with 2mM L-glutamine + 20% FBS https://ww...

  • IST-MES1

    IST-MES1

    Immunology Shirley (New York) September 30, 2026 1.00 Dollar US$

    Cat.No. CSC-6273W Description established from the pleural effusion of a 70- year- old Caucasian woman with pleural epithelioid mesothelioma Species Homo sapiens (Human) Source Pleural Effusion https://www.creative-bioarray.com/ist-mes1-csc-6273w-ite...

  • IST-MES2

    IST-MES2

    Immunology Shirley (New York) September 30, 2026 1.00 Dollar US$

    Cat.No. CSC-6274W Description established from the pleural effusion of a 71- year- old Caucasian man with pleural epithelioid mesothelioma Species Homo sapiens (Human) Source Pleural Effusion https://www.creative-bioarray.com/ist-mes2-csc-6274w-item-...

  • MPP 89

    MPP 89

    Drug Development Shirley (New York) September 30, 2026 1.00 Dollar US$

    Cat.No. CSC-6299W Description Species: human male 67 years old; Tissue: pleural effusion; Tumor: mesothelioma Species Homo sapiens (Human) Source Pleural Effusion https://www.creative-bioarray.com/MPP-89-CSC-6299W-item-1022.htm

  • MEL-290

    MEL-290

    Immunology Shirley (New York) September 30, 2026 1.00 Dollar US$

    Cat.No. CSC-C7075J Description established from the uvea of a woman with uveal melanoma Species Homo sapiens (Human) Source Eye; Uvea Recommended Medium RPMI 1640 + 20% FBS https://www.creative-bioarray.com/mel-290-csc-c7075j-item-49118.htm

  • MP38

    MP38

    Immunology Shirley (New York) September 30, 2026 1.00 Dollar US$

    Cat.No. CSC-C7067J Description established from the uvea tissue of a male patient with uveal melanoma Species Homo sapiens (Human) Source Eye; Uvea Recommended Medium RPMI-1640 + 20% FBS https://www.creative-bioarray.com/mp38-csc-c7067j-item-49110.ht...

  • HSC-5

    HSC-5

    Immunology Shirley (New York) September 30, 2026 1.00 Dollar US$

    Cat.No. CSC-C6901J Description A cell line derived from human skin squamous cell carcinoma having anaplastic epithelioid features. Species Homo sapiens (Human) Source Skin https://www.creative-bioarray.com/hsc-5-csc-c6901j-item-44240.htm

  • HCA-1

    HCA-1

    Immunology Shirley (New York) September 30, 2026 1.00 Dollar US$

    Cat.No. CSC-C6920J Description Human endocervical adenocarcinoma cell line. Species Homo sapiens (Human) Source Lymph Node Metastasis https://www.creative-bioarray.com/hca-1-csc-c6920j-item-44259.htm

  • 143B

    143B

    Drug Development Shirley (New York) September 30, 2026 1.00 Dollar US$

    Cat.No. CSC-C9149W Description This is a human osteosarcoma cell line, thymidine kinase negative (TK-) Species Homo sapiens (Human) Source Bone https://www.creative-bioarray.com/143B-CSC-C9149W-item-42082.htm

  • HS-SY-II

    HS-SY-II

    Drug Development Shirley (New York) September 30, 2026 1.00 Dollar US$

    Cat.No. CSC-C6322J Description Human cell line derived from synovial sarcoma. Species Homo sapiens (Human) Source Pleural Effusion Metastasis https://www.creative-bioarray.com/hs-sy-ii-item-csc-c6322j-42922.htm